Michael Trauner

67.2k total citations · 21 hit papers
867 papers, 39.1k citations indexed

About

Michael Trauner is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Michael Trauner has authored 867 papers receiving a total of 39.1k indexed citations (citations by other indexed papers that have themselves been cited), including 496 papers in Epidemiology, 477 papers in Hepatology and 279 papers in Surgery. Recurrent topics in Michael Trauner's work include Liver Disease Diagnosis and Treatment (463 papers), Liver Disease and Transplantation (262 papers) and Drug Transport and Resistance Mechanisms (182 papers). Michael Trauner is often cited by papers focused on Liver Disease Diagnosis and Treatment (463 papers), Liver Disease and Transplantation (262 papers) and Drug Transport and Resistance Mechanisms (182 papers). Michael Trauner collaborates with scholars based in Austria, United States and Germany. Michael Trauner's co-authors include Peter Fickert, Gernot Zollner, Martin Wagner, James L. Boyer, Thomas Reiberger, Emina Halilbasic, Marco Arrese, Peter L. M. Jansen, Thierry Claudel and Helmut Denk and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

Michael Trauner

828 papers receiving 38.5k citations

Hit Papers

Detection of Various... 1998 2026 2007 2016 2019 2011 2003 2006 1998 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Detection of Various Microplastics in Human Stool
    2019 1.3k citations Philipp Schwabl, Theresa Bucsics et al. profile →
  2. The interaction of hepatic lipid and glucose metabolism in liver diseases
    2011 762 citations Michael Trauner et al. Journal of Hepatology profile →
  3. Bile Salt Transporters: Molecular Characterization, Function, and Regulation
    2003 751 citations Michael Trauner et al. profile →
  4. Characterization of HULC, a Novel Gene With Striking Up-Regulation in Hepatocellular Carcinoma, as Noncoding RNA
    2006 665 citations Katrin Panzitt, Tarek Moustafa et al. Gastroenterology profile →
  5. Molecular Pathogenesis of Cholestasis
    1998 540 citations Michael Trauner et al. profile →
  6. Bile acid receptors as targets for drug development
    2013 531 citations Michael Trauner et al. profile →
  7. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome
    2020 505 citations Michael Trauner et al. profile →
  8. Bile acids and nonalcoholic fatty liver disease
    2016 478 citations Juan Pablo Arab, Marco Arrese et al. Hepatology profile →
  9. Gut-liver axis: Pathophysiological concepts and clinical implications
    2022 426 citations Michael Trauner et al. profile →
  10. Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
    2018 422 citations Juan Pablo Arab, Marco Arrese et al. Annual Review of Pathology Mechanisms of Disease profile →
  11. Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
    2014 421 citations Michael Trauner, Hanns–Ulrich Marschall et al. Gastroenterology profile →
  12. New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond
    2015 395 citations Michael Trauner et al. Journal of Hepatology profile →
  13. Targeting the gut-liver axis in liver disease
    2017 318 citations Michael Trauner et al. Journal of Hepatology profile →
  14. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology
    2022 289 citations Claudia Fuchs, Michael Trauner profile →
  15. The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis
    2019 205 citations Michael Trauner, Andrew J. Muir et al. Hepatology profile →
  16. Current treatment of non‐alcoholic fatty liver disease
    2022 178 citations Rafael Paternostro, Michael Trauner profile →
  17. EASL Clinical Practice Guidelines on sclerosing cholangitis
    2022 175 citations Michael Trauner et al. Journal of Hepatology profile →
  18. Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease
    2022 111 citations Péter Ferenci, Michael Trauner et al. Journal of Hepatology profile →
  19. FXR agonists in NASH treatment
    2023 90 citations Michael Trauner et al. Journal of Hepatology profile →
  20. Bile acid metabolism and signalling in liver disease
    2024 40 citations Claudia Fuchs, Benedikt Simbrunner et al. Journal of Hepatology profile →
  21. Primary sclerosing cholangitis
    2025 13 citations Andrew J. Muir, Michael Trauner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Trauner Austria 100 18.4k 14.9k 12.5k 12.0k 6.8k 867 39.1k
Gregory J. Gores United States 142 20.1k 1.1× 19.0k 1.3× 14.2k 1.1× 23.6k 2.0× 19.3k 2.8× 591 63.2k
Kazuaki Chayama Japan 99 15.7k 0.9× 14.9k 1.0× 7.4k 0.6× 10.7k 0.9× 7.5k 1.1× 1.4k 45.3k
Hartmut Jaeschke United States 107 9.1k 0.5× 12.2k 0.8× 5.6k 0.4× 6.5k 0.5× 8.2k 1.2× 399 34.7k
Hanns–Ulrich Marschall Sweden 60 6.0k 0.3× 4.5k 0.3× 7.5k 0.6× 6.8k 0.6× 4.6k 0.7× 208 17.5k
Neil Kaplowitz United States 95 9.7k 0.5× 7.9k 0.5× 4.4k 0.4× 2.7k 0.2× 8.4k 1.2× 314 30.6k
Elizabeth M. Brunt United States 81 39.0k 2.1× 17.5k 1.2× 3.5k 0.3× 8.9k 0.7× 8.2k 1.2× 273 50.2k
Herbert Tilg Austria 87 18.1k 1.0× 5.0k 0.3× 3.6k 0.3× 5.8k 0.5× 12.1k 1.8× 452 40.3k
Kris V. Kowdley United States 86 20.1k 1.1× 14.5k 1.0× 2.9k 0.2× 5.6k 0.5× 3.2k 0.5× 451 29.4k
Anna Mae Diehl United States 114 35.4k 1.9× 16.2k 1.1× 3.1k 0.3× 8.5k 0.7× 13.3k 2.0× 407 51.5k
Shinji Üemoto Japan 79 6.7k 0.4× 13.9k 0.9× 4.5k 0.4× 15.3k 1.3× 3.2k 0.5× 954 26.7k

Countries citing papers authored by Michael Trauner

Since Specialization
Citations

This map shows the geographic impact of Michael Trauner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Trauner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Trauner more than expected).

Fields of papers citing papers by Michael Trauner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Trauner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Trauner. The network helps show where Michael Trauner may publish in the future.

Co-authorship network of co-authors of Michael Trauner

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Trauner. A scholar is included among the top collaborators of Michael Trauner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Trauner. Michael Trauner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwarz, Birgit, et al.. (2024). From LAL-D to MASLD: Insights into the role of LAL and Kupffer cells in liver inflammation and lipid metabolism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1870(1). 159575–159575. 1 indexed citations
2.
3.
Hartl, Lukas, Daniel Moritz Felsenreich, Julia Jedamzik, et al.. (2024). Rapid improvement of hepatic steatosis and liver stiffness after metabolic/bariatric surgery: a prospective study. Scientific Reports. 14(1). 17558–17558. 6 indexed citations
4.
Dixon, Emmanuel D., Thierry Claudel, Alexander D Nardo, et al.. (2024). Inhibition of ATGL alleviates MASH via impaired PPARα signalling that favours hydrophilic bile acid composition in mice. Journal of Hepatology. 82(4). 658–675. 15 indexed citations
5.
Straub, Tobias, Jana Krietsch, Andrea Sanchi, et al.. (2023). Single molecule MATAC-seq reveals key determinants of DNA replication origin efficiency. Nucleic Acids Research. 51(22). 12303–12324. 1 indexed citations
6.
Hendrikx, Tim, Florentina Porsch, Máté G. Kiss, et al.. (2022). Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH. Journal of Hepatology. 77(5). 1373–1385. 125 indexed citations
7.
Mayer, Katharina A., Ursula Smole, Sophia Derdak, et al.. (2021). The energy sensor AMPK orchestrates metabolic and translational adaptation in expanding T helper cells. The FASEB Journal. 35(4). e21217–e21217. 14 indexed citations
8.
Sanyal, Arun J., Quentin M. Anstee, Michael Trauner, et al.. (2021). Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis. Hepatology. 75(5). 1235–1246. 89 indexed citations
9.
Halilbasic, Emina, Martin Gajdošík, Marek Chmelík, et al.. (2021). Concentration of Gallbladder Phosphatidylcholine in Cholangiopathies: A Phosphorus‐31 Magnetic Resonance Spectroscopy Pilot Study. Journal of Magnetic Resonance Imaging. 55(2). 530–540. 3 indexed citations
10.
Semmler, Georg, Benedikt Simbrunner, Bernhard Scheiner, et al.. (2019). Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension. Journal of Gastroenterology and Hepatology. 34(12). 2164–2172. 10 indexed citations
11.
Al-Dury, Samer, Annika Wahlström, Katrin Panzitt, et al.. (2019). Obeticholic acid may increase the risk of gallstone formation in susceptible patients. Journal of Hepatology. 71(5). 986–991. 49 indexed citations
12.
Arab, Juan Pablo, Marco Arrese, & Michael Trauner. (2018). Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease. Annual Review of Pathology Mechanisms of Disease. 13(1). 321–350. 422 indexed citations breakdown →
13.
Pinter, Matthias, Florian Hucke, Simona Bota, et al.. (2017). The impact of thyroid hormones on patients with hepatocellular carcinoma. PLoS ONE. 12(8). e0181878–e0181878. 24 indexed citations
14.
Primas, Christian, et al.. (2016). Dynamics of occurrence of refractory coeliac disease and associated complications over 25 years. Alimentary Pharmacology & Therapeutics. 45(2). 364–372. 33 indexed citations
15.
Reiberger, Thomas, Gregor Ulbrich, Arnulf Ferlitsch, et al.. (2012). Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut. 62(11). 1634–1641. 228 indexed citations
16.
Das, Suman K., Sandra Eder, Silvia Schauer, et al.. (2011). Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia. Science. 333(6039). 233–238. 441 indexed citations
17.
Zollner, Gernot, Martin Wagner, Tarek Moustafa, et al.. (2005). Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-α/β in the adaptive response to bile acids. American Journal of Physiology-Gastrointestinal and Liver Physiology. 290(5). G923–G932. 146 indexed citations
18.
Pizarro, Margarita, Natarajan Balasubramaniyan, Nancy Solı́s, et al.. (2004). Bile secretory function in the obese Zucker rat: evidence of cholestasis and altered canalicular transport function. Gut. 53(12). 1837–1843. 72 indexed citations
19.
Wagner, Martin, Peter Fickert, Gernot Zollner, et al.. (2003). Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology. 125(3). 825–838. 216 indexed citations
20.
Trauner, Michael, et al.. (2002). Groin Eruption in an HIV-Positive Man. Archives of Dermatology. 138(4). 527–527. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gregory J. Gores Breakdown of academic impact, for papers by Kazuaki Chayama Breakdown of academic impact, for papers by Hartmut Jaeschke Breakdown of academic impact, for papers by Hanns–Ulrich Marschall Breakdown of academic impact, for papers by Neil Kaplowitz Breakdown of academic impact, for papers by Elizabeth M. Brunt Breakdown of academic impact, for papers by Herbert Tilg Breakdown of academic impact, for papers by Kris V. Kowdley Breakdown of academic impact, for papers by Anna Mae Diehl Breakdown of academic impact, for papers by Shinji Üemoto
Rankless by CCL
2026